Hydroxocobalamin Interference With Chromogenic Anti-Xa Assay in a Patient on Mechanical Circulatory Support

被引：2
|
作者：
Cagle, Grant [1 ]
Greene, Rebecca A. [2 ,3 ]
机构：
[1] Rhode Isl Hosp, Div Pulm Crit Care & Sleep Med, Providence, RI USA
[2] Rhode Isl Hosp, Dept Pharm, Providence, RI USA
[3] 593 Eddy St, Providence, RI 02903 USA
来源：
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA | 2023年 / 37卷 / 07期
关键词：
hydroxocobalamin; Cyanokit; analytical interference; anti-Xa; vasoplegia; anticoagulation; VASOPLEGIC SYNDROME; METHYLENE-BLUE; SURGERY; HEPARIN; TESTS;
D O I：
10.1053/j.jvca.2023.02.035
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
[No abstract available]
引用
收藏
页码：1241 / 1244
页数：4
相关论文
共 50 条
  • [31] Brief communication: Heparin-calibrated chromogenic anti-Xa assay for the detection of threshold-levels of direct oral anticoagulants
    De Smet, Delphine
    Hemelsoet, Dimitri
    De Herdt, Veerle
    De Kesel, Pieter M.
    Devreese, Katrien M. J.
    [J]. INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2024,
  • [32] Clinical laboratory measurement of direct factor Xa inhibitors: Anti-Xa assay is preferable to prothrombin time assay
    Barrett, Yu Chen
    Wang, Zhaoqing
    Frost, Charles
    Shenker, Andrew
    [J]. THROMBOSIS AND HAEMOSTASIS, 2010, 104 (06) : 1263 - 1271
  • [33] Assessment of apixaban on automated analyzers using a Liquid Anti-Xa assay
    Cao, Z.
    Kung, C.
    Bottenus, R.
    Triscott, M.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 951 - 952
  • [34] Comparison of calibrated chromogenic anti-Xa assay and PT tests with LC-MS/MS for the therapeutic monitoring of patients treated with rivaroxaban
    Douxfils, Jonathan
    Tamigniau, Anne
    Chatelain, Bernard
    Chatelain, Christian
    Wallemacq, Pierre
    Dogne, Jean-Michel
    Mullier, Francois
    [J]. THROMBOSIS AND HAEMOSTASIS, 2013, 110 (04) : 723 - 731
  • [35] Results of Heptest anti Xa assay with manual, mechanical and photo-optical techniques differ from chromogenic anti Xa results in enoxaparin therapy
    Kitchen, S
    Rand, E
    Woolley, A
    Preston, FE
    [J]. THROMBOSIS AND HAEMOSTASIS, 1999, : 858 - 858
  • [36] Using an old test for new tricks: Measuring direct oral anti-Xa drug levels by conventional heparin-calibrated anti-Xa assay
    Maier, Cheryl L.
    Asbury, William H.
    Duncan, Alexander
    Robbins, Adele
    Ingle, Ann
    Webb, Adam
    Stowell, Sean R.
    Roback, John D.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (05) : E132 - E134
  • [37] A comprehensive evaluation of factors effecting range and precision for heparin Anti-IIa and Anti-Xa chromogenic assays
    Shaklee, P.
    Shaklee, M. J.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 1092 - 1092
  • [38] Heparin-calibrated chromogenic anti-Xa assays are not suitable to assess the presence of significant direct factor Xa inhibitors levels
    Sabor, Lina
    Raphael, Melanie
    Dogne, Jean-Michel
    Mullier, Francois
    Douxfils, Jonathan
    [J]. THROMBOSIS RESEARCH, 2017, 156 : 36 - 38
  • [39] Monitoring of heparin therapy beyond the anti-Xa activity assay: Evaluation of a thrombin generation assay
    Vermeiren, Pauline
    Vandevelde, Arne
    Peperstraete, Harlinde
    Devreese, Katrien M. J.
    [J]. INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2022, : 785 - 795
  • [40] Reassessment of dextran sulfate in anti-Xa assay for unfractionated heparin laboratory monitoring
    Hardy, Michael
    Cabo, Julien
    Deliege, Antoine
    Douxfils, Jonathan
    Gouin-Thibault, Isabelle
    Lecompte, Thomas
    Mullier, Francois
    [J]. RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2023, 7 (08)
12345